Dr. Joanne McKell, MD interviews Dr. Erika Moseson, MD, MA physician and podcaster, about her road to environmental advocacy despite a heavy clinical and administrative workload, a pandemic, and a young family. Dr. Moseson is the creator and host of Air Health, Our Health, a host of the ATS podcast Out of the Blue, and member of the ATS Environmental Health Policy committee.
*Produced by the EOPH Assembly
Host: Joanne McKell, MD, Case Western Reserve University School of Medicine
Guest: Erika Mosesón, MD, MA, Pulmonary Section Chair at Legacy Emanuel Health Medical Center
In this episode, Dr. Joanne McKell, MD sits down with Dr. Mary Rice, MD, MPH Chair of the Environmental, Occupational, and Population Health (EOPH) Assembly of the American Thoracic Society. Dr. Rice shares her journey into environmental health, her goals as Chair, and how her clinical work in pulmonary medicine informs her research on air pollution and climate change.
*Produced by the EOPH Assembly
00:01:20 | Early Influences & Environmental Awareness
00:02:30 | From Consulting to Medicine
00:03:30 | The Path to Pulmonary Medicine
00:04:50 | Joining and Leading Within ATS
00:06:10 | Inside the Role of an Assembly Chair
00:07:50 | Goals for the Year Ahead
00:09:10 | The Power of Framing in Science Communication
00:10:50 | Balancing Clinical Practice and Leadership
00:12:30 | Optimism, Perseverance, and Closing Reflections
Host: Joanne L. McKell, MD, Case Western Reserve University School of Medicine
Guest: Mary B. Rice, MD, MPH, Harvard Medical School, Harvard TH Chan School of Public Health
An in-depth exploration of the evolving understanding of inflammation in COPD, focusing on the differences between type 1/3 and type 2 inflammatory pathways and their clinical relevance. Experts will discuss current gaps in COPD management and the potential of precision medicine to improve outcomes for patients with persistent symptoms or frequent exacerbations. The program will also review recent clinical trial data on type 2 biologics, strategies for identifying appropriate candidates through biomarkers and comorbidities, and key areas for future research, including long-term outcomes, treatment tapering, and therapy optimization.
Host:
• Sara Assaf, MD - Assistant Professor, Division of Pulmonary, Critical Care and Sleep at the University of New Mexico
Guests
• Nick Hanania, MD, MS - Director, Airways Clinical Research Center, Brown Foundation, Professor of Medicine, Baylor College of Medicine
• Stephanie Christenson, MD MAS - Associate Professor, Division of Pulmonary, Critical Care, Allergy, & Sleep, UCSF
• Surya P Bhatt MD, MSPH - Professor of Medicine, Endowed Professor of Airways Disease, University of Alabama at Birmingham
• Klaus Rabe, MD, PhD, FERS - Professor of Pulmonary Medicine, University of Kiel
🔹 00:00:00 | Introduction (0–4 min)
🔹 00:04:04 | Setting the Stage: Why Type 2 Inflammation Matters in COPD
🔹 00:08:07 | The Science Behind COPD and Type 2 Pathways
🔹 00:12:08 | How Inflammation Shapes Disease Progression
🔹 00:16:11 | Current and Emerging Treatments for COPD
🔹 00:24:20 | Biomarkers and Precision Medicine
🔹 00:32:25 | New Frontiers and Ongoing Research
🔹 00:52:41 | Wrapping Up and Key Takeaways
Field walking tests are common outcome measures used in pulmonary rehabilitation to measure an individual's exercise capacity. With a growing number of other outcome measures that also assess exercise capacity, should people still continue to use field walking tests? This podcast aims to highlight why field walking tests should still be used and the common pitfalls when executing these tests.
00:00 – Introduction
02:10 – Why Field Walking Tests Matter
06:25 – The Big Three Tests
12:40 – Choosing the Right Test
13:20 – Limitations of Current Field Tests
13:35 – Emerging Role of Step Tests
15:05 – Three Key Takeaways (Dr. Machado)
16:45 – Closing Remarks
17:30 – Outro
**Produced by the PR Assembly
The intersection of pulmonary and palliative medicine is particularly relevant in the care of patients with interstitial lung disease (ILD). The complex medical, psychological, and physical needs of this population necessitate a collaborative approach, integrating the expertise of both specialties. Approaching care with curiosity rather than judgment fosters interdisciplinary partnership, leading to more comprehensive, patient-centered strategies that enhance outcomes for ILD patients and their caregivers across all dimensions of care.
#PulmonaryPalliativeCare
#AdvancedLungDisease
#InterstitialLungDisease
#Partnerships #Collaboration
#PalliativeMedicine #ATS #AAHPM #WESCOEfoundation #AdvancedIllnessPlanning #GoalsOfCare #TeamBasedCare #WholePersonCare #BeCuriousNotJudgmental
*Produced by the BSHSR Assembly